Exelixis Inc
(NAS:EXEL)
$
35.91
0.06 (0.17%)
Market Cap: 10.26 Bil
Enterprise Value: 9.24 Bil
PE Ratio: 23.02
PB Ratio: 4.51
GF Score: 91/100 
Exelixis Inc at SVB Leerink Global Healthcare Conference (Virtual) Transcript
Feb 26, 2021 / 06:00PM GMT
Release Date Price:
$21.66
(-1.37%)
Andrew Scott Berens
SVB Leerink LLC, Research Division - MD of Targeted Oncology & Senior Research Analyst
Good afternoon, everyone. I'm Andrew Berens, Senior Biotech Analyst and Head of Target Oncology for SVB Leerink. Thank you for joining us on the final day of our Global Healthcare Conference.
We are very pleased to have Exelixis with us. We have Michael Morrissey, the President and CEO. Thank you for joining us, Mike. We really appreciate your time.
Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director
Thanks, Andrew. Great to be here. Thanks for the invite.
Andrew Scott Berens
SVB Leerink LLC, Research Division - MD of Targeted Oncology & Senior Research Analyst
Of course. No, we appreciate it.
Questions & Answers
Andrew Scott Berens
SVB Leerink LLC, Research Division - MD of Targeted Oncology & Senior Research Analyst
So for those on the webcast that may not be familiar with your company, can you give us an
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers